임상 레이더 AI | ||
|---|---|---|
임상시험 NCT07493525은(는) 1형 근긴장성 근이영양증, 낙상에 대해 진행중, 모집종료 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요. | ||
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰
Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1 41 관찰 연구
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '임상시험 설명'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT07493525은(는) 1형 근긴장성 근이영양증, 낙상에 대해 알아보는 관찰연구입니다. 현재 상태는 진행중, 모집종료이며, 연구는 2025년 6월 20일에 시작되어 41명의 참여자를 모집하고 있습니다. Antalya Training and Research Hospital이(가) 진행하며, 2026년 6월 15일까지 완료될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2026년 3월 25일에 갱신되었습니다.
간단한 개요
This cross-sectional observational study aims to determine the frequency of falls in patients with myotonic dystrophy type 1 and to identify factors affecting dynamic balance. The study will also evaluate fear of falling, selected lower extremity muscle strength, and the relationship between muscle strength and fall frequency. The findings may contribute to a better understanding of fall risk and balance impairment i...더 보기
상세한 설명
Myotonic dystrophy type 1 is a multisystem neuromuscular disorder characterized by myotonia, progressive muscle weakness, and functional limitations. Distal muscle weakness, impaired postural control, and gait dysfunction may increase the risk of falls and negatively affect daily activities and quality of life. Although falls and balance impairment are clinically important in patients with myotonic dystrophy type 1, ...더 보기
공식 제목
Determination of Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1: A Cross-Sectional Observational Single-Center Study
질환명
1형 근긴장성 근이영양증낙상출판물
이 임상시험에 대해 발표된 과학 논문 및 연구 자료.기타 연구 식별자
- 2025-217
NCT 번호
실제 연구 시작일
2025-06-20
최신 업데이트 게시
2026-03-25
예상 연구 완료일
2026-06-15
계획된 등록 인원
41
연구종류
관찰연구
상태
진행중, 모집종료
키워드
dynamic balance
falls
fall frequency
fear of falling
muscle strenght
neuromuscular disease
postural control
gait
balance impairment
rehabilitation
falls
fall frequency
fear of falling
muscle strenght
neuromuscular disease
postural control
gait
balance impairment
rehabilitation
시험군 / 개입
| 참가자 그룹/시험군 | 개입/치료 |
|---|---|
Myotonic Dystrophy Type 1 Group Patients with myotonic dystrophy type 1 who are evaluated for fall frequency, dynamic balance, fear of falling, and lower extremity muscle strength. | 해당 없음 |
주요결과변수
이차결과변수
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
Fall frequency | Fall frequency will be assessed using semi-structured questions regarding the number of falls experienced by patients with myotonic dystrophy type 1. | At baseline |
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
Fear of falling | Fear of falling will be assessed using semi-structured questions regarding the fear of falling experienced by patients with myotonic dystrophy type 1. | At baseline |
Muscular Impairment Rating Scale score | Disease-related muscle involvement severity will be assessed using the Muscular Impairment Rating Scale (MIRS). | At baseline |
Dynamic balance performance by Timed Up and Go test | Dynamic balance performance will be assessed using the Timed Up and Go (TUG) test. | At baseline |
Walking performance by 10-Meter Walk Test at maximum safe speed | Walking performance and dynamic mobility will be assessed using the 10-Meter Walk Test at maximum safe speed. | At baseline |
Isometric muscle strength | Isometric muscle strength of selected muscle groups will be measured to evaluate the relationship between muscle strength and fall frequency. | At baseline |
Hand grip strength | Hand grip strength will be measured using a hand grip strength assessment. | At baseline |
Balance performance by Berg Balance Scale | Balance performance will be evaluated using the Berg Balance Scale. | At baseline |
Functional Ambulation Scale score | Ambulation level will be recorded using the Functional Ambulation Scale (FAS). | At baseline |
참여 도우미
적격성 기준
연령대
성인
최소 연령
18 Years
참여 가능한 성별
전체
- Adults aged between 18 and 60 years old
- Diagnosis of myotonic dystrophy type 1
- Ability to understand and follow study instructions
- Ability to ambulate, with or without an assistive device, sufficiently to perform the study assessments
- Willingness to participate and provide written informed consent
- Severe cognitive impairment interfering with understanding or completion of the study assessments
- Severe visual impairment interfering with balance and mobility testing
- Severe sensory impairment, including markedly impaired vibration sensation, that may affect balance assessment
- Any additional neurological, musculoskeletal, vestibular, or other medical condition that could substantially affect gait, balance, or fall risk independently of myotonic dystrophy type 1
- Acute medical condition or unstable clinical status at the time of assessment
- Inability to complete the study evaluations
Antalya Training and Research Hospital연구 책임자
Ceren Arslan, 책임연구자, Resident Physician, Antalya Training and Research Hospital
연락처 정보가 없습니다.
1 1개국에 임상시험 장소
Antalya
Antalya Training and Research Hospital, Antalya, Antalya, 07100, Turkey (Türkiye)